Pledgeted versus nonpledgeted sutures in aortic valve replacement: Insights from a prospective multicenter trial.

AVR, aortic valve replacement BMI, body mass index BSA, body surface area EOA, effective orifice area EOAi, effective orifice area indexed LVOT, left ventricular outflow tract PERIGON, PERIcardial SurGical AOrtic Valve ReplacemeNt PPM, prosthesis–patient mismatch PVL, paravalvular leak STS, Society of Thoracic Surgeons endocarditis paravalvular leak pledgets surgical aortic valve replacement suturing technique thromboembolism

Journal

JTCVS techniques
ISSN: 2666-2507
Titre abrégé: JTCVS Tech
Pays: United States
ID NLM: 101768546

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 12 06 2022
revised: 20 10 2022
accepted: 24 10 2022
entrez: 23 2 2023
pubmed: 24 2 2023
medline: 24 2 2023
Statut: epublish

Résumé

The objective of this study was to compare short- and midterm clinical and echocardiographic outcomes according to the use of pledgeted sutures during aortic valve replacement. Patients with aortic stenosis or regurgitation requiring aortic valve replacement were enrolled in a prospective cohort study to evaluate the safety of a new stented bioprosthesis. Outcomes were analyzed according to the use of pledgets (pledgeted group) or no pledgets (nonpledgeted group). The primary outcome was a composite of thromboembolism, endocarditis, and major paravalvular leak at 5 years of follow-up. Secondary outcomes included multiple clinical endpoints and hemodynamic outcomes. Propensity score matching was performed to adjust for prognostic factors, and subanalyses with small valve sizes (<23 mm) and suturing techniques were performed. The pledgeted group comprised 640 patients (59%), and the nonpledgeted group 442 (41%), with baseline discrepancies in demographic characteristics, comorbidities, and stenosis severity. There were no differences between groups in any outcome. After propensity score matching, the primary outcome occurred in 41 (11.7%) patients in the pledgeted and 36 (9.8%) in the nonpledgeted group ( In this large propensity score-matched cohort, comprehensive clinical outcomes were comparable between patients who underwent aortic valve replacement with pledgeted and nonpledgeted sutures up to 5 years of follow-up, but pledgets might lead to a slightly smaller effective orifice area in the long run.

Identifiants

pubmed: 36820352
doi: 10.1016/j.xjtc.2022.10.016
pii: S2666-2507(22)00542-9
pmc: PMC9938379
doi:

Types de publication

Journal Article

Langues

eng

Pagination

23-46

Informations de copyright

© 2022 The Author(s).

Références

J Thorac Cardiovasc Surg. 2014 Oct;148(4):1347-51
pubmed: 24518226
J Thorac Cardiovasc Surg. 2014 Jan;147(1):321-5
pubmed: 23228405
Ann Thorac Surg. 2020 Mar;109(3):661-667
pubmed: 31604093
Ann Thorac Surg. 2019 Jan;107(1):24-32
pubmed: 30423335
Eur Heart J. 2021 May 14;42(19):1825-1857
pubmed: 33871579
Eur J Cardiothorac Surg. 2017 Sep 01;52(3):425-431
pubmed: 28475690
Eur J Cardiothorac Surg. 2005 Dec;28(6):838-43
pubmed: 16275007
JACC Cardiovasc Interv. 2022 Apr 25;15(8):901
pubmed: 35450690
J Thorac Cardiovasc Surg. 2011 Feb;141(2):388-93
pubmed: 20488465
J Thorac Cardiovasc Surg. 2018 Oct;156(4):1368-1377.e5
pubmed: 29778342
J Thorac Cardiovasc Surg. 2022 Sep;164(3):822-829.e6
pubmed: 33339597

Auteurs

Bart J J Velders (BJJ)

Department of Cardiothoracic Surgery, Leiden University Medical Centre, Leiden, the Netherlands.

Michiel D Vriesendorp (MD)

Department of Cardiothoracic Surgery, Leiden University Medical Centre, Leiden, the Netherlands.

Joseph F Sabik (JF)

Department of Surgery, University Hospitals, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Francois Dagenais (F)

Division of Cardiac Surgery, Quebec Heart and Lung Institute, Quebec, Quebec, Canada.

Louis Labrousse (L)

Medico-Surgical Department of Valvulopathies, Bordeaux Heart University Hospital, Bourdeaux-Pessac, France.

Vinayak Bapat (V)

Department of Cardiothoracic Surgery, NHS Foundation Trust-St Thomas' Hospital, London, United Kingdom.

Gabriel S Aldea (GS)

Department of Cardiothoracic Surgery, University of Washington School of Medicine, Seattle, Wash.

Anelechi C Anyanwu (AC)

Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, New York, NY.

Yaping Cai (Y)

Core Clinical Solutions, Medtronic, Mounds View, Minn.

Robert J M Klautz (RJM)

Department of Cardiothoracic Surgery, Leiden University Medical Centre, Leiden, the Netherlands.

Classifications MeSH